We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UL icon
501
Unilever
UL
$143B
$2.97M 0.01%
40,665
+1,920
+5% +$133K
K
502
DELISTED
Kellanova
K
$2.96M 0.01%
36,663
-1,166
-3% -$83K
DOV icon
503
Dover
DOV
$26.8B
$2.91M 0.01%
15,166
+147
+1% +$26.8K
NDAQ icon
504
Nasdaq
NDAQ
$53.9B
$2.91M 0.01%
39,805
-3,669
-8% -$250K
LUV icon
505
Southwest Airlines
LUV
$22B
$2.89M 0.01%
97,634
+43,106
+79% +$1.19M
XLU icon
506
State Street Utilities Select Sector SPDR ETF
XLU
$23.2B
$2.88M 0.01%
71,378
+1,730
+2% +$64.2K
BAX icon
507
Baxter International
BAX
$12.7B
$2.88M 0.01%
75,843
+1,702
+2% +$62.5K
GLW icon
508
Corning
GLW
$107B
$2.87M 0.01%
63,475
-2,657
-4% -$112K
EAGL
509
Eagle Capital Select Equity ETF
EAGL
$4.47B
$2.85M 0.01%
+104,150
New +$2.76M
EME icon
510
Emcor
EME
$30B
$2.85M 0.01%
6,613
-106
-2% -$40K
GEHC icon
511
GE HealthCare
GEHC
$32.4B
$2.83M 0.01%
30,173
+180
+0.6% +$15.1K
MMSI icon
512
Merit Medical Systems
MMSI
$4.74B
$2.83M 0.01%
28,637
+170
+0.6% +$15.6K
VCR icon
513
Vanguard Consumer Discretionary ETF
VCR
$6.02B
$2.82M 0.01%
8,290
+400
+5% +$128K
JCI icon
514
Johnson Controls International
JCI
$85.5B
$2.79M 0.01%
36,009
-10,140
-22% -$711K
ICLR icon
515
Icon
ICLR
$14B
$2.77M 0.01%
9,633
-30
-0.3% -$9.46K
IWY icon
516
iShares Russell Top 200 Growth ETF
IWY
$15.5B
$2.76M 0.01%
12,558
– –
MSI icon
517
Motorola Solutions
MSI
$72.7B
$2.76M 0.01%
6,144
+89
+1% +$37.1K
ES icon
518
Eversource Energy
ES
$28.1B
$2.76M 0.01%
40,595
-14,824
-27% -$958K
OEF icon
519
iShares S&P 100 ETF
OEF
$19.8B
$2.71M 0.01%
9,807
– –
KWR icon
520
Quaker Houghton
KWR
$2.56B
$2.71M 0.01%
16,108
+4,454
+38% +$753K
GSK icon
521
GSK
GSK
$106B
$2.69M 0.01%
65,877
-5,633
-8% -$230K
GLPI icon
522
Gaming and Leisure Properties
GLPI
$13B
$2.66M 0.01%
51,796
+3,592
+7% +$178K
VXF icon
523
Vanguard Extended Market ETF
VXF
$30.2B
$2.66M 0.01%
14,643
– –
KEYS icon
524
Keysight
KEYS
$51B
$2.65M 0.01%
16,680
-2,972
-15% -$423K
WU icon
525
Western Union
WU
$2.55B
$2.65M 0.01%
221,962
-762,832
-77% -$9.2M
19 20
21
22 23

Similar funds

EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.